Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Announces Early Access Program for Imaging Mass Cytometry Platform

Premium

NEW YORK (GenomeWeb) – Fluidigm this week announced that it plans by the end of the year to launch an early access program for its upcoming imaging mass cytometry platform.

Based on Fluidigm's CyTOF mass cytometry platform and research by University of Zurich researcher Bernd Bodenmiller, the platform allows users to obtain spatial and expression information on up to 30 proteins simultaneously at the single-cell level, the company said.

This "extension of mass cytometry combines an upfront laser ablation module with the CyTOF platform," Gajus Worthington, Fluidigm president and CEO, said in a statement. "This will enable scientists to track protein identity, quantity, and location within a tissue sample, allowing entirely new studies of cellular heterogeneity and function.”

Fluidigm has begun accepting applications for early access to the device.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.